Received Jul 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7NX57 | — |
an adult who received a pediatric dose of Hep B vaccine/ she only had half a dose; an adult who received a pediatric dose of Hep B vaccine/Unapproved age; This non-serious case was reported by a nurse via call center representative and described the occurrence of underdose in a 35-year-old female patient who received HBV (Engerix B pediatric) (batch number 7NX57, expiry date 12-DEC-2026) for prophylaxis. On 30-JUN-2025, the patient received Engerix B pediatric. On 30-JUN-2025, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: an adult who received a pediatric dose of Hep B vaccine/ she only had half a dose) and adult use of a child product (Verbatim: an adult who received a pediatric dose of Hep B vaccine/Unapproved age). The outcome of the underdose and adult use of a child product were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-JUN-2025 Nurse had a patient, an adult who received a pediatric dose of Hep B vaccine, which led to an adult use of a child product and underdose. Nurse questioned what was and what they do because she only had half a dose. Did they have to came her back for a second pediatric dose to equal to 1 ml.